Role of Pittsburgh modified TNM criteria in prognosis prediction of liver transplantation for hepatocellular carcinoma

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2200-2203

  Chen, Jun ^a   Xu, Xiao ^a   Ling, Qi ^a   Wu, Jian ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Pittsburgh modified TNM criteria

Indexed keywords

ALPHA FETOPROTEIN; CYCLOSPORIN; EPIRUBICIN; FLUOROURACIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXALIPLATIN; STEROID; TACROLIMUS;

ACCURACY; ARTICLE; CANCER STAGING; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OVERALL SURVIVAL; PITTSBURGH MODIFIED TNM CRITERIA; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; RADIOFREQUENCY ABLATION; RELIABILITY; SURVIVAL RATE;

EID: 38349097319     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00008     Document Type: Article

References (26)

1. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma: the tumor node-metastasis classification does not have prognostic power. Hepatology 1998; 27: 1572-1577.
2. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000; 88: 538-543.
3. Marsh JW, Dvorchik I, Iwatsuki S. Liver transplantation in the treatment of hepatocellular carcinoma. J Hepato-Biliary-Pancreat Surg 1998; 5: 24-28.
4. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005; 100: 2708-2716.
5. Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I, et al. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002; 26: 257-263.
6. International Union Against Cancer (UICC). In: Sobin LH, Wittekind CH, eds. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997: 74-77.
7. Mazzaferro, V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
8. Lau H, Fan ST, Ng IO, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998; 83: 2302-2311.
9. Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998; 4: 1475-1482.
10. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K. Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 1998; 83: 58-63.
11. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C, et al. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 1998; 227: 424-432.
12. Honda K, Sbisa E, Tullo A, Papeo PA, Saccone C, Poole S, et al. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumor ablation. Br J Cancer 1998; 77: 776-782.
13. Klintmalm GB. Liver transplantation for hepatocellular carcinoma. Ann Surg 1998; 228: 479-490.
14. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
15. Vivarelli M, Cucchetti A, Piscaglia, F, La Barba G, Bolondi L, Cavallari A, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma. Key role of immunosuppression. Liver Transpl 2005; 11: 497-503.
16. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10: 534-540.
17. Lee HH, Joh JW, Park JH, Lee KW, Kim SJ, Heo JS, et al. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma. Transplant Proc 2005; 37: 1251-1253.
18. Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, et al. Impact of histological grade of hepatocellutar carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136: 25-30.
19. Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004; 239: 150-159.
20. Sauer P, Kraus TW, Schemmer P, Mehrabi A, Stremmel W, Buechler MW, et al. Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the selection criteria? Transplantation 2005; 80: S105-S108.
21. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
22. Fernandez JA, Robles R, Marin C, Sanchez-Bueno F, Ramirez P, Pons JA, et al. Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant Proc 2003; 35: 1818-1820.
23. Leung JY, Zhu AX, Gordon FD, Prat DST, Mithoefer A, Garrigan K, et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 2004; 10: 1343-1354.
24. Karakayali H, Moray G, Sozen H, Dalgic A, Emiroglu R, Haberal M. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. Transplant Proc 2006; 38: 575-578.
25. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774.
26. Dumortier J, Lombard-Bohas C, Valette PJ, Boillot O, Scoazec JY, Berger F, et al. Needle tract recurrence of hepatocellular carcinoma after liver transplantation. Gut 2000; 47: 301.